Last reviewed · How we verify
Influenza Vaccine GSK1247446A
Influenza Vaccine GSK1247446A is a Biologic drug developed by GlaxoSmithKline. It is currently in Phase 2 development.
At a glance
| Generic name | Influenza Vaccine GSK1247446A |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Revaccination With Influenza Vaccine GSK1247446A (PHASE2)
- Study to Evaluate an Influenza Vaccine Candidate (PHASE2)
- Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate (PHASE2)
- Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate (PHASE2)
- Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate (PHASE2)
- Study to Evaluate an Influenza Vaccine Candidate (PHASE2)
- Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Influenza Vaccine GSK1247446A CI brief — competitive landscape report
- Influenza Vaccine GSK1247446A updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Influenza Vaccine GSK1247446A
What is Influenza Vaccine GSK1247446A?
Influenza Vaccine GSK1247446A is a Biologic drug developed by GlaxoSmithKline.
Who makes Influenza Vaccine GSK1247446A?
Influenza Vaccine GSK1247446A is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
What development phase is Influenza Vaccine GSK1247446A in?
Influenza Vaccine GSK1247446A is in Phase 2.
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Compare: Influenza Vaccine GSK1247446A vs similar drugs
- Pricing: Influenza Vaccine GSK1247446A cost, discount & access